Fiasp

Fiasp

Novo Nordisk

Fiasp (insulin aspart injection) is a rapid-acting insulin used to improve blood glucose in adults and children (age 2 years and older) with diabetes. Fiasp is delivered via vial and syringe, pen, cartridge or pump.


Features


Specs

Insulin Type:
Rapid-acting
Generic Name:
Insulin aspart
Delivery:
Syringe, pen, cartridge or pump
Form:
Analog
Concentrations:
U-100
Onset:
16 to 20 min.
Peak:
91 to 133 min.
Duration:
5 to 7 hours